The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why?
Investors and entrepreneurs will track decisions affecting drugs, medical devices and telehealth.
Elon Musk, Vivek Ramaswamy and RFK Jr. appear poised to have Trump’s ear in positions that don’t require Senate confirmation ...
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
The death penalty for trafficking, border militarization and coerced treatment are on the agenda, even if the tone on ...
The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...
From family planning to hospital bills, the new Trump administration has the potential to affect a wide range of policies in ...
The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...
This approach enables an ongoing dialogue between the regulatory body and drug developers. Expediting the review process ...
"The FDA's approval of Lumryz was not arbitrary or capricious," U.S. District Judge Amit P. Mehta wrote in a memorandum ...
The unlisted ingredients can cause "life threatening" drops in blood pressure when used in combination with other prescription drugs, the agency warns.